Monday, June 7, 2021
- 6:00pm-6:05pm
-
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of At-1501
Kidney Immunosuppression • Virtual
- 6:00pm-6:05pm
-
Dna-pkcs Regulation of the Allogeneic Immune Response
- 6:00pm-6:05pm
-
Initial Kidney Transplant Evaluations with Telehealth: Is it a Pandemic Only Practice?
- 6:00pm-6:05pm
-
Pediatric Donation During COVID-19 Pandemic
Liver Pediatrics • Virtual
- 6:00pm-6:05pm
-
Randomized Phase 3 Open-label Study of Maribavir vs Investigator-assigned Therapy for Refractory/resistant Cytomegalovirus Infection in Transplant Recipients: Subgroup Analyses of Efficacy by Organ
Late Breaking: Basic & ID • Virtual
- 6:00pm-6:05pm
-
Sequential Analysis of Renal Allograft Rejection at Single Cell Resolution
Lymphocyte Biology and Tolerance • Virtual
- 6:00pm-6:05pm
-
VP2 MRNA Distinguishes the Direct Injury and Inflammation Effects of Polyoma Virus (BK) Infection from the Cognate TCMR Response That Follows Immunosuppressive Minimization
BK virus in Kidney Recipients • Virtual
- 6:05pm-6:10pm
-
Coexistence of BKPyV Lytic Infection and Viral Integration in the Development of BKPyV Diseases After Renal Transplantation
BK virus in Kidney Recipients • Virtual
- 6:05pm-6:10pm
-
Evaluation of a Weight-Based Mycophenolate Mofetil Dosing Protocol for Kidney Transplant Maintenance Immunosuppression
Kidney Immunosuppression • Virtual
- 6:05pm-6:10pm
-
Life-supporting Multi-gene Cardiac Xenografts From Swine Demonstrate Survival >8 Months and Preclinical Efficacy for Human Clinical Trials
Late Breaking: Basic & ID • Virtual
- «Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 14
- Next Page»